Advertisement

Indications for Surgical Treatment of Ulcerative Colitis

  • Zoran V. Krivokapic
  • Goran I. Barisic

Keywords

Ulcerative Colitis Rectal Stump Toxic Megacolon Severe Ulcerative Colitis Fulminant Colitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stewenius J, Adnerhill I, Ekelund GR et al (1996) Operations in unselected patients with ulcerative colitis and indeterminate colitis: a long term follow-up study. Eur J Surg 162:131PubMedGoogle Scholar
  2. 2.
    Robert JH, Sachar DB, Aufses AH Jr et al (1990) Management of severe hemorrhage in ulcerative colitis. Am J Surg 159:550PubMedGoogle Scholar
  3. 3.
    Mallant-Hent RCh, van Bodegraven AA, Meuwissen SG, Manoliu RA (2003) Alternative approach to massive gastrointestinal bleeding in ulcerative colitis: highly selective transcatheter embolisation. Eur J Gastroenterol Hepatol 15(2):189–193PubMedCrossRefGoogle Scholar
  4. 4.
    Pesce G, Ceccarino R (1991) Treatment of severe hemorrhage from a defunctionalized rectum with adrenaline chloride in ulcerative colitis. Dis Colon Rectum 34:1139PubMedCrossRefGoogle Scholar
  5. 5.
    Michelassi F, Finco C (1995) Indications for surgery in inflammatory bowel disease: the surgeon’s perspective. In: Kirsner JB, Shorter RG (eds) Inflammatory bowel disease, 4th edn. Williams, Baltimore, pp 771–783Google Scholar
  6. 6.
    Truelove SC, Witts LJ (1995) Cortisone in ulcerative colitis: final report on a therapeutic trial. BMJ 2:1041CrossRefGoogle Scholar
  7. 7.
    Travis SPL, Farrant JM, Ricketts C et al (1996) Predicting outcome in severe colitis. Gut 38:905PubMedGoogle Scholar
  8. 8.
    Fazio VW (1980) Toxic megacolon in ulcerative colitis and Crohn’s colitis. Gastroenterol 9:389–407Google Scholar
  9. 9.
    Lichtiger S, Present DH, Kornbluth A et al (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330:1841PubMedCrossRefGoogle Scholar
  10. 10.
    Marion JF, Present DH (1997) The modern medical management of acute, severe ulcerative colitis. Eur J Gastroenterol Hepatol 9:831–835PubMedGoogle Scholar
  11. 11.
    Daperno M, Sostegni R, Scaglione N et al (2004) Outcome of a conservative approach in severe ulcerative colitis. Dig Liver Dis 36:4–6CrossRefGoogle Scholar
  12. 12.
    Rayner CK, McCormack G, Emmanuel AV, Kamm MA (2003) Long-term results of low-dose intravenous ciclosporin for acute severe ulcerative colitis. Aliment Pharmacol Ther 18:303–308PubMedCrossRefGoogle Scholar
  13. 13.
    D’Haens G, Lemmens L, Geboes K et al (2001) Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 120:1323–1329PubMedCrossRefGoogle Scholar
  14. 14.
    Kohn A, Prantera C, Pera A, Cosintino R et al (2002) Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients. Dig Liver Dis 34:626–630PubMedCrossRefGoogle Scholar
  15. 15.
    Lam EC, Bailey RJ (2003) Infliximab salvage therapy after cyclosporine in an acute flare of chronic ulcerative colitis. Can J Gastroenterol 17:198–200PubMedGoogle Scholar
  16. 16.
    Ljung T, Karlen P, Schmidt D et al (2004) Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County. Gut 53:849–853PubMedCrossRefGoogle Scholar
  17. 17.
    Bell RL, Seymour NE (2002) Laparoscopic treatment of fulminant ulcerative colitis. Surg Endosc 16:1778–1782PubMedCrossRefGoogle Scholar
  18. 18.
    Marohn MR, Hanly EJ, McKenna KJ, Varin CR (2005) Laparoscopic total abdominal colectomy in the acute setting. Gastrointest Surg 9:881–886CrossRefGoogle Scholar
  19. 19.
    Sachar DB (2000) Indications for surgery in inflammatory bowel disease: a gastroenterologist’s opinion. In: Kirsner JB (ed) Inflammatory bowel disease, vol 4. Saunders, Philadelphia, pp 611–615Google Scholar
  20. 20.
    Grieco MB, Bordan DL, Geiss AC et al (1980) Toxic megacolon complicating Crohn’s colitis. Ann Surg 191:75–80PubMedGoogle Scholar
  21. 21.
    Latella G, Vernia P, Viscido A et al (2002) GI distension in severe ulcerative colitis. Am J Gastroenterol 97:169–175CrossRefGoogle Scholar
  22. 22.
    Goligher JC, Hoffman DC, DeDombal FT et al (1970) Surgical treatment of severe attacks of ulcerative colitis, with special reference to the advantages of early operation. BMJ 4:703–706PubMedCrossRefGoogle Scholar
  23. 23.
    Amico C, Vitale A, Angriman I et al (2005) Early surgery for the treatment of toxic megacolon. Digestion 72:146–149PubMedCrossRefGoogle Scholar
  24. 24.
    Katzka I, Katz S, Morris E (1979) Management of toxic megacolon: the significance of early recognition in medical management. J Clin Gastroenterol 1:307–301PubMedCrossRefGoogle Scholar
  25. 25.
    Present DH, Wolfson D, Gelernt IM et al (1988) Medical decompression of toxic megacolon by “rolling”: a new technique of decompression with favorable long-term follow-up. J Clin Gastroenterol 10:485–490PubMedCrossRefGoogle Scholar
  26. 26.
    Kuroki K, Masuda A, Uehara H, Kuroki A (1998) A new treatment for toxic megacolon. Lancet 352:782PubMedCrossRefGoogle Scholar
  27. 27.
    Pascu M, Muller AR, Wiedenmann D, Dignass AU (2003) Rescue therapy with tacrolimus in a patient with toxic megacolon. Int J Colorectal Dis 18:271–275PubMedGoogle Scholar
  28. 28.
    Sawada K, Egashira A, Ohnishi K et al (2005) Leukocytapheresis (LCAP) for management of fulminant ulcerative colitis with toxic megacolon. Dig Dis Sci 50:767–773PubMedCrossRefGoogle Scholar
  29. 29.
    Greenstein AJ, Barth JA, Sachar DB et al (1985) Outcome of toxic dilatation in ulcerative and Crohn’s colitis. J Clin Gastroenterol 7:137PubMedCrossRefGoogle Scholar
  30. 30.
    JJ Tjandra (1999) Toxic colitis and perforation. In: Michelassi F Milsom JW (eds) Operative strategies in inflammatory bowel disease. Springer, Berlin Heidelberg New York, pp 234–245Google Scholar
  31. 31.
    Dozois RR, Kelly KA (2000) The surgical management of ulcerative colitis. In: Kirsner JB (ed) Inflammatory bowel disease. Saunders, Philadelphia, pp 626–657Google Scholar
  32. 32.
    Järnerot G, Rolny P, Sandberg-Gertzen H (1985) Intensive intravenous treatment of ulcerative colitis. Gastroenterology 89:1005PubMedGoogle Scholar
  33. 33.
    Actis GC (2000) Cyclosporin for steroid-refractory ulcerative colitis. Am J Gastroenterology 95:830CrossRefGoogle Scholar
  34. 34.
    Bousvaros A, Kirschner BS, Werlin SL et al (2000) Oral tacrolimus treatment of severe colitis in children. J Pediatr 137:794–799PubMedCrossRefGoogle Scholar
  35. 35.
    D’Haens G (2005) Infliximab for ulcerative colitis: finally some answers. Gastroenterology 128:2161–2164PubMedCrossRefGoogle Scholar
  36. 36.
    Nishioka C, Aoyama N, Maekawa S (2005) Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy. J Gastroenterol Hepatol 20:1567–1571PubMedCrossRefGoogle Scholar
  37. 37.
    Britton A, Peppercorn MA (1995) Emergencies in inflamatory bowel diseases. Crit Care Clin 11:513–529Google Scholar
  38. 38.
    Choi PM, Zelig MP (1994) Similarity of colorectal cancer in CD and UC: implications for carcinogenesis and prevention. Gut 35:950–954PubMedGoogle Scholar
  39. 39.
    Ransohoff D (1988) Colon cancer in ulcerative colitis. Gastroenterology 94:1089PubMedGoogle Scholar
  40. 40.
    Eaden JA, Abrams KR, Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta analysis. Gut 48:526–535PubMedCrossRefGoogle Scholar
  41. 41.
    Ekborn A, Helmick C, Zack M, Adami HO (1990) Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med 323:1228–1233CrossRefGoogle Scholar
  42. 42.
    Riddell RH, Goldman H, Ransohoff DF et al (1983) Dysplasia in inflammatory bowel disease: standardised classification with provisional clinical applications. Hum Pathol 14:931–968PubMedCrossRefGoogle Scholar
  43. 43.
    Rosenstock E, Farmer RG, Petras R et al (1990) Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 89:1342–1346Google Scholar
  44. 44.
    Lofberg R, Brostrom O, Karlen P et al (1990) Colonoscopic surveillance in long-standing total ulcerative colitis: a 15-year follow-up study. Gastroenterology 99:1021–1031PubMedGoogle Scholar
  45. 45.
    Ransohoff Df, Riddell RH, Levin B (1985) Ulcerative colitis and colonic cancer: Problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum 28:383PubMedCrossRefGoogle Scholar
  46. 46.
    Melville DMN, Jass JR, Morson BC et al (1998) Observer study on the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. Hum Pathol 20:1990Google Scholar
  47. 47.
    Lim CH, Dixon MF, Vail A et al (2003) Ten year follow up of ulcerative colitis patients with and without low-grade dysplasia. Gut 52:127–113CrossRefGoogle Scholar
  48. 48.
    Befrits R, Ljung T, Jaramillo E, Rubio C (2002) Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. Dis Colon Rectum 45:615–620PubMedCrossRefGoogle Scholar
  49. 49.
    Ulman TA, Loftus VE, Kakar S et al (2002) The fate of low-grade dysplasia in ulcerative colitis. Am J Gastroenterol 97:922–927CrossRefGoogle Scholar
  50. 50.
    Bernstein CN, Shanahan F, Weinstein WM (1994) Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 8:71–74Google Scholar
  51. 51.
    Ullman TA (2003) Patients with low-grade dysplasia should be advised to undergo colectomy. Inflamm Bowel Dis 9:267–269PubMedCrossRefGoogle Scholar
  52. 52.
    Ullman T, Croog V, Harpaz N et al (2003) Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 125:1311–1319PubMedCrossRefGoogle Scholar
  53. 53.
    Blackstone MO, Riddel RH, Rogers BH, Levin B (1981) Dysplasia associated lession or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 80:366–374PubMedGoogle Scholar
  54. 54.
    Connel WR, Lennard-Jones JE, Williams CB et al (1994) Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 107:934–944Google Scholar

Copyright information

© Springer-Verlag Italia 2006

Authors and Affiliations

  • Zoran V. Krivokapic
    • 1
  • Goran I. Barisic
    • 1
  1. 1.Institute for Digestive DiseasesBelgradeSerbia-Montenegro

Personalised recommendations